Abstract
Objectives & BackgroundDabigatran, an oral thrombin inhibitor, is widely used for stroke prevention in atrial fibrillation. Idarucizumab, a monoclonal antibody fragment directed against dabigatran, demonstrated immediate, complete and sustained reversal...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have